About Smith & Nephew

Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively — and patients get back to their normal lives faster. Our dedicated Global Business Units — Orthopaedic Reconstruction, Orthopaedic Trauma, Biologics & Spine, Endoscopy and Advanced Wound Management — specialize in innovative, cost-effective products that meet pressing healthcare needs.

With the help of our products and our support for healthcare professionals; doctors, nurses and surgeons can provide treatment more quickly and economically — and with better results. Patients enjoy improved mobility or flexibility, recover from surgery quicker, find their conditions easier to manage and see an improved quality of life. These benefits are encapsulated in the ambition that shapes our entire business: Helping people regain their lives.

For more information on Smith & Nephew, please see the Smith & Nephew website.

Q-MED

Q-MED AB is a Swedish biotechnology/medical device company that develops, produces, markets and sells medical implants.

All products are based on the company's patented technology for the production of stabilized non-animal hyaluronic acid, NASHA™. DUROLANE is manufactured by Q-MED for Smith & Nephew for the treatment of osteoarthritis of the hip and knee joints.

The company's head office and production facility is based in Uppsala, Sweden.

For more information visit www.q-med.com.

WorldWide

DUROLANE is now marketed and distributed worldwide by Smith & Nephew, Inc. under a license agreement with Q-Med AB. Durolane has regulatory approval in most European countries, Canada and Indonesia, with additional countries being added periodically. DUROLANE is not approved in the United States at this time.

If you have questions about DUROLANE, would like to place an order or have any other inquiry, please contact us.